Secondary Progressive MS Trial of Lamotrigine Tested For Neuroprotection Benefits
Posted by: Ayesha Khan January 31, 2014 A recently completed study at University College London Hospital suggests that administration of certain drugs…
Research showing advances in Axon restoration, cognitive performance, And a hopeful medication for Primary & Secondary-progressive multiple sclerosis
Posted by: Maureen Newman February 28, 2014 Fresh from the Multiple Sclerosis Association of America (MSAA) is the 2014 MS Research Update, published each year, MS…
Stuart Schlossman
Secondary Progressive Multiple Sclerosis EBV Adoptive Immunotherapy Shows Promise
Posted by: Maureen Newman February 10, 2014 Professor Michael Pender, of the University of Queensland School of Medicine, Brisbane,…
Stuart Schlossman
Secondary Progressive MS Research Into Natalizumab Continues To Progress
Posted by: Mike Nace February 6, 2014 Researchers continue to explore different treatment approaches for secondary progressive MS, ranging from the development…
Stuart Schlossman
SPMS (Secondary Progressive MS) – Causes Plus Symptoms & Diagnosis
Symptoms & Diagnosis of SPMS SPMS symptoms are not necessarily different from the symptoms that govern Multiple Sclerosis overall; the…
Stuart Schlossman
Secondary Progressive MS: What You Need To Know
Secondary Progressive MS: What You Need To Know Multiple Sclerosis (MS) is a disease that features several distinct patterns of…
Stuart Schlossman
Experimental Drug Proves Effective As Secondary Progressive Multiple Sclerosis Treatment
Posted by: Chris Comish February 3, 2014 New Zealand-based Innate Immunotherapeutics has been in the news as of late, making headlines about the…
Stuart Schlossman
Tcelna – formerly known as Tovaxin – continues research study for SPMS
a Hopeful medication for Secondary MS (SPMS ) Tcelna® (imilecleucel-T) Tcelna® (formerly known as Tovaxin) is a personalized T-cell immunotherapy in a…
Stuart Schlossman
PPMS Study taking place at DUKE UNIVERSITY in North Carolina – ‘RECLASSIFYING MULTIPLE SCLEROSIS’
ABOUT the Study: Brief History and Description The MURDOCK Study – Measurement to Understand the Reclassification of Disease Of Cabarrus /…
Stuart Schlossman
